Australian cosmetic and aesthetic clinics.
Cosmetic is the highest-review-load category in healthcare advertising — and the 2024–25 guidance refresh raised the floor again.
The reality
Cosmetic advertising is the most heavily reviewed corner of Australian healthcare marketing, and the rules tightened materially from 2 September 2025. Every before-and-after image, testimonial, influencer post and trade-name reference now sits under a regime that audits, prosecutes and publishes outcomes — and the practitioner, not the agency, carries the consequence.
Who regulates you
Cosmetic advertising sits inside three frames at once, not one.
The first is the Health Practitioner Regulation National Law, administered by the Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia. Section 133 prohibits false, misleading or deceptive claims, undisclosed inducements, testimonials about clinical care, unreasonable expectations of benefit, and content that encourages indiscriminate or unnecessary use. The cross-Board Guidelines for advertising a regulated health service sit beneath section 133.
The second is the Guidelines for practitioners who advertise higher risk non-surgical cosmetic procedures, in force from 2 September 2025. They require real, unedited images with a results-may-vary warning, ban influencer testimonials and endorsements, restrict before-and-after imagery, prohibit trivialisation or sexualisation, ban advertising aimed at under-18s, and require total-price disclosure. A companion performance guideline sets a seven-day cooling-off rule for under-18s and minimum experience thresholds for nurses. For cosmetic surgery, only holders of the Medical Board endorsement in cosmetic surgery — in force since 1 July 2023 — may use the title "cosmetic surgeon"; GP referral is mandatory.
The third is therapeutic-goods law. Section 42DLB of the Therapeutic Goods Act 1989 prohibits any direct or indirect consumer-facing reference to a Schedule 4 substance — trade names, lookalike euphemisms ("wrinkle reducing injections") and promoting a health service as a route to a prescription medicine all sit inside the prohibition. Pricing and comparative claims outside clinical care fall within the Australian Consumer Law. Before-and-after image consent and patient data are governed by the Privacy Act 1988, regulated by the Office of the Australian Information Commissioner.
The stakes
Section 133 maxima sit at $60,000 per offence for an individual practitioner and $120,000 per offence for a body corporate, applying nationally from July 2024 per the AHPRA advertising compliance and enforcement strategy. Each non-compliant advertisement is a separate offence.
The cosmetic sector has been audited harder than any other. The Independent Review of the Regulation of Medical Practitioners who perform Cosmetic Surgery reported in August 2022 with sixteen recommendations, all accepted. The standing Cosmetic Surgery Enforcement Unit that followed, backed by $4.5 million, had closed 200 notifications by April 2024, with more than 35 practitioners facing regulatory action and 315 active investigations underway. Daniel Lanzer surrendered his medical registration on 2 December 2021 after the Four Corners broadcast; his earlier Federal Court application to restrain the program was refused. AHPRA imposed extensive practice and social-media conditions on Dr Daniel Aronov, barring him from any cosmetic or surgical procedure and requiring removal of cosmetic content from his social accounts. Other Lanzer-network practitioners carry suspensions, supervision conditions and restricted scope on the public register.
The TGA layer is moving in parallel. In 2024–25 the TGA requested removal of more than 13,700 unlawful advertisements from digital platforms and issued infringement notices up to $13,320 per contravention for individuals and $66,600 for corporate entities, with civil penalties under the Act reaching $1.65 million per breach for individuals and $16.5 million for corporations.
Why most agencies get this wrong
Two failure modes recur, and both end on the practitioner's record.
The generalist who ports the global cosmetic playbook. An agency built for international aesthetics or e-commerce drops the standard kit into an Australian clinic — transformation slider, results testimonial reel, before-and-after gallery, paid creator post tagging the injectable brand. Each is a section 133 breach in plain sight. From 2 September 2025 the influencer post, airbrushed image and trivialising caption breach the cosmetic overlay; the trade-name reference breaches section 42DLB. The agency invoices and moves on. The practitioner inherits the AHPRA notification.
The cautious agency that ships nothing. Faced with a regime they cannot read, the agency strips every claim, image and price out until the clinic site reads like a directory listing. Defensible, inert. Acquisition stalls. The principal concludes marketing does not work for cosmetic, when in fact the agency could not see what was permitted.
You may recognise one of these from past engagements.
Why compliance done right is a moat
Cosmetic is the highest-review-load category in Australian healthcare advertising, and the guidance keeps refreshing. Agencies that brief from the regulatory spec — section 133, the September 2025 cosmetic guidelines and section 42DLB as the starting frame rather than a clean-up step — produce work that survives every revision. Those that do not, ship work that has to be redrawn the next time AHPRA publishes a clarification. The constraint itself filters out competitors who cannot operate inside it, which is precisely what makes the inside of the regime defensible. The clinics that win this category are not the ones that try hardest. They are the ones whose marketing does not need redrawing every quarter.
The Regimen approach
Regimen is built for regulated Australian professional services. Compliance review runs on every piece of work we ship — copy, creative, landing pages, paid media, organic content — against AHPRA advertising guidelines, the cosmetic guidelines from 2 September 2025, the Medical Board endorsement framework, section 42DLB, the Australian Consumer Law and the Privacy Act. We know the seams: where the standard rules and the cosmetic overlay collide, where trade-name references break under section 42DLB, and where before-and-after imagery survives the new visual rules.
If you run a cosmetic surgery practice, an injectables clinic, a laser or skin clinic or a day surgery and you want marketing that converts inside the rules rather than around them, book a 30-minute discovery call. We will tell you, on the call, whether your current advertising would survive an AHPRA audit.
One vertical in five. Each with its own seams.